568 related articles for article (PubMed ID: 17851846)
21. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
[TBL] [Abstract][Full Text] [Related]
22. Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis.
Zhu H; Zhou Z; Wang Y; Bi N; Feng Q; Li J; Lv J; Chen D; Shi Y; Wang L
Cancer; 2011 Dec; 117(23):5423-31. PubMed ID: 21563176
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.
Watkins JM; Wahlquist AE; Shirai K; Garrett-Mayer E; Aguero EG; Fortney JA; Sherman CA; Sharma AK
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1108-13. PubMed ID: 19084345
[TBL] [Abstract][Full Text] [Related]
24. Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
Gridelli C; Curcio C; Iaffaioli RV; Brancaccio L; D'Aprile M; Gebbia V; Rossi A; Tortoriello A; Veltri E; Maione P; Barbarisi A; Gallo C; Guida C; Perrone F
Anticancer Res; 2001; 21(6A):4179-83. PubMed ID: 11911315
[TBL] [Abstract][Full Text] [Related]
25. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
Jeremić B; Milicić B
Cancer; 2008 Feb; 112(4):876-84. PubMed ID: 18172901
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
27. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.
Lebeau B; Urban T; Bréchot JM; Paillotin D; Vincent J; Leclerc P; Meekel P; L'Her P; Lebas FX; Chastang C
Cancer; 1999 Oct; 86(8):1480-7. PubMed ID: 10526276
[TBL] [Abstract][Full Text] [Related]
28. Randomized phase 2 study of subcutaneous amifostine versus epoetin-alpha given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer.
Han HS; Han JY; Yu SY; Pyo HR; Kim HY; Cho KH; Lee DH; Kim HT; Lee JS
Cancer; 2008 Oct; 113(7):1623-31. PubMed ID: 18671241
[TBL] [Abstract][Full Text] [Related]
29. [Preliminary results of three-dimensional conformal radiotherapy for small-cell lung cancer].
Wang YJ; Wang LH; Chen DF; Zhou ZM; Ou GF; Liang J; Zhang K; Yin WB
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):570-2. PubMed ID: 16438861
[TBL] [Abstract][Full Text] [Related]
30. Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study.
Le QT; McCoy J; Williamson S; Ryu J; Gaspar LE; Edelman MJ; Dakhil SR; Sides SD; Crowley JJ; Gandara DR;
Clin Cancer Res; 2004 Aug; 10(16):5418-24. PubMed ID: 15328179
[TBL] [Abstract][Full Text] [Related]
31. Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial.
Blackstock AW; Bogart JA; Matthews C; Lovato JF; McCoy T; Livengood K; Ho C; White D; Atkins JN; Miller AA
Clin Lung Cancer; 2005 Mar; 6(5):287-92. PubMed ID: 15845179
[TBL] [Abstract][Full Text] [Related]
32. Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy.
Graham PH; Clark C; Abell F; Browne L; Capp A; Clingan P; De Sousa P; Fox C; Links M
Australas Radiol; 2006 Aug; 50(4):342-8. PubMed ID: 16884421
[TBL] [Abstract][Full Text] [Related]
33. Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer.
Ziske C; Gorschlüter M; Mey U; Offergeld R; Glasmacher A; Schmidt-Wolf IG
Anticancer Res; 2002; 22(6B):3723-6. PubMed ID: 12552983
[TBL] [Abstract][Full Text] [Related]
34. An accelerated radiotherapy scheme using a concomitant boost technique for the treatment of unresectable stage III non-small cell lung cancer.
Izmirli M; Yaman F; Buyukpolat MY; Yoney A; Unsal M
Jpn J Clin Oncol; 2005 May; 35(5):239-44. PubMed ID: 15886271
[TBL] [Abstract][Full Text] [Related]
35. Different fraction schedules and combinations with chemotherapy in radiation treatment of non-small cell lung cancer.
Brattström D; Bergqvist M; Hesselius P; Wagenius G; Brodin O
Anticancer Res; 2000; 20(3B):2087-90. PubMed ID: 10928157
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
Alshehadat S; Sahmoun AE
Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
[TBL] [Abstract][Full Text] [Related]
37. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation.
Tsujino K; Hirota S; Kotani Y; Kado T; Yoden E; Fujii O; Soejima T; Adachi S; Takada Y
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1100-5. PubMed ID: 16373082
[TBL] [Abstract][Full Text] [Related]
38. Changes in patterns of care for limited-stage small-cell lung cancer: results of the 99-01 patterns of care study-a nationwide survey in Japan.
Uno T; Sumi M; Ishihara Y; Numasaki H; Mitsumori M; Teshima T;
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):414-9. PubMed ID: 18164865
[TBL] [Abstract][Full Text] [Related]
39. Influence of interfraction interval on local tumor control in patients with limited-disease small-cell lung cancer treated with radiochemotherapy.
Jeremić B; Milićić B
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):426-32. PubMed ID: 17306936
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Unsal M; Erturk D
Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
